Blog Layout

Market Commentary | July 2021

Rob Kellogg, CFA®

Aug 05, 2021

As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.

THE MARKET

Equity markets experienced a historic month in November as the S&P 500 finished up 10.75% and is now up 12.10% on the year. 

The Dow Jones Industrial Average (DJIA) is now up 3.86% on the year after finishing the month of November up 11.84%. The technology heavy NASDAQ continues to perform well in 2020 as it is now up 35.96% on the year after finishing the month up 11.80%. Small cap stocks led the monthly performance numbers as the Russell 2000 is now up on the year by 9.07% after a tremendous month of November saw it increase by 18.29%.1 That is the strongest ever monthly performance for the index.2 Monday, November 30th, saw a dip in the markets to close out the month as monthly rebalancing likely trimmed the equity exposure in portfolios and investors were eager to lock in the gains experienced in November.

IMPACT OF THE ELECTION AND THE VIRUS

A large part of the monthly gains can likely be attributed to two factors. The U.S. Presidential Election has led to political certainty and there was positive news surrounding a COVID-19 vaccine. Investors are in favor of the political certainty as President Elect Joe Biden was able to defeat President Donald Trump in the November 3rd election. President Trump continues to contest the election, but he has yet to have any significant wins in court. President Elect Biden named Janet Yellen as his pick for U.S. Treasury Secretary. It is not expected to face much resistance in the Senate; however, she will need 51 votes to be confirmed. If Republicans maintain their majority of 52 seats after the Georgia runoff, Democrats will need to swing 3 senators to confirm her. If she is confirmed, she will be the first female to hold the role. She will be a welcome sight for Progressives as she served as the Chair of the Federal Reserve during the former President Obama’s second term. She was later replaced by Jerome Powell as Chair after Trump’s 2016 campaign targeted her for keeping interest rates too low. Current Secretary Mnuchin said that he will work with his successor “if things get certified,” which should further put investors’ minds at ease.3


As the election results became clearer, so too, did news regarding vaccine trials. Pfizer, BioNTech, Moderna, and AstraZeneca all announced positive news regarding late stage trials of a vaccine.4 From the perspective of many investors, this positive news was able to outweigh the increased number of virus cases, thus causing markets to rally throughout the month. The image to the right shows the daily number of virus cases throughout the year.


The United Kingdom gave emergency authorization on Wednesday, December 2nd, to Pfizer’s coronavirus vaccine. This makes them the first Western country to approve a vaccine for distribution. With the vaccine being codeveloped by an American company, this authorization puts more pressure on U.S. regulators to move faster.6 Federal government officials are promising that a vaccine will come soon, and some have even said before Christmas.7 However, only a limited number of vaccines will be available for immediate distribution following any sort of approval. As a result, a plan must be put in place to best curb the spread of the virus and to protect those most at risk. In a recent meeting, the Centers for Disease Control and Prevention (CDC) voted on which groups of people will be the first to receive the vaccine. In a 13-to-1 vote, it was decided that health care workers and residents of nursing homes and other residential care facilities will be first in line.8 The rest of the country may have to wait until late spring or potentially even until the summer of 2021.7 While we still may be months away from a widely distributable vaccine, the recent news on effectiveness of the vaccines and the news from Britain shows us that there is a light at the end of the tunnel.

CONCLUSION

With all of the news surrounding the election, the virus, and the markets, it can be difficult, and certainly stressful contemplating your investments. The good news is that you shouldn’t have to make sense of it all. Your financial plans should be built based on your own risk tolerance and your own financial objectives. The ebbs and flows of the markets will come and go with each new headline and each passing day, but your portfolios should be built to withstand the volatility. We will inevitably experience more negative news surrounding the virus. There are likely to be more lockdowns in certain parts of the country and visiting family over Christmas could become more controversial than it was over the Thanksgiving break. There will be positive news too. Recent unemployment applications fell last week after a recent jump signaling that layoffs are easing, even though they remain high as the labor market continues to recover.10 More positive developments on the vaccine front are likely as well. The resulting short term market fluctuations may be tough to look at as they scroll across the bottom of your television, but it is important to remember that your money exposed to this risk is meant for longer term goals. Remember to maintain your disciplined investment approach and take the emotion out of investing. Understanding your portfolio is about understanding expectations. It’s about having a sense of how your portfolio is designed and how it should behave over meaningful periods of time. Having a sense of how the investments should react to certain movements in the market. Having a dynamic plan in place should put your mind at ease when volatility is high. Please don’t hesitate to reach out if you’d like to revisit your risk tolerance and asset allocation. It is important that you feel comfortable about your current portfolio as December is likely to continue with the volatility seen thus far in 2020.

1 https://www.investing.com/indices/

2 https://www.reuters.com/article/us-usa-stocks/sp-500-ends-down-after-rallying-to-best-november-ever-idUSKBN28A1MH

3 https://www.foxbusiness.com/markets/if-treasury-secretary-janet-yellen-make-history

4 https://www.cnbc.com/2020/12/01/world-stocks-outperform-the-us-in-bumper-november.html

5 https://covid.cdc.gov/covid-data-tracker/#trends_totalandratecases

6 https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html

7 https://www.cnn.com/2020/11/30/health/covid-vaccine-questions-when/index.html

8 https://www.webmd.com/lung/news/20201201/cdc-votes-on-who-should-get-covid-vaccine-first

9 https://www.juliusbaer.com/es/insights/artificial-intelligence/the-robots-keep-coming-finance-gets-techier/

10 https://www.wsj.com/articles/weekly-jobless-claims-coronavirus-13-2-2020-11606950268

 21

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

Index Returns (as of 11/30/2020) Level November QTD YTD
S&P 500 3621 10.75% 7.69% 12.10%
Dow Jones Industrial Average 29639 11.84% 6.68% 3.86%
NASDAQ Composite 12199 11.80% 9.23% 35.96%
Russell 2000 1820 18.29% 20.70% 9.07%
MSCI EAFE 2054 15.38% 10.70% 0.83%
MSCI Emerging Markets 1205 9.21% 11.37% 8.11%
U.S. Aggregate Bond - 0.98% 0.62% 7.36%

Source (1)

Source (5)

Source (9)

THE MARKET

The S&P 500 continued to climb for the fifth straight month as the index hit a new all-time high on July 29th.1 The index finished the month up 2.27% and is now up 17.02% on the year. The Dow Jones Industrial Average (DJIA) and the NASDAQ Composite both increased during the month as well finishing up 1.26% and 1.20% respectively. Both indices are now comfortably in double digit returns for the year. Small cap stocks took a significant hit as the Russell 2000 fell 3.65% during the month, but it is still up 12.73% on the year. As investors move some of their equity gains into fixed income and the Fed continues with their asset purchases, bond demand has increased leading to a return of 1.12% for the U.S. Agg in the month of July. It is now down just 0.50% on the year.2

Index Returns (as of 7/30/2021) Level July/QTD YTD
S&P 500 4,395.26 2.27% 17.02%
Dow Jones Industrial Average 34,936.13 1.26% 14.15%
NASDAQ Composite 14,672.70 1.20% 13.80%
Russell 2000 2,226.25 -3.65% 12.73%
MSCI EAFE 2,321.09 0.70% 8.08%
MSCI Emerging Markets 1,277.80 -7.04% -1.04%
U.S. Aggregate Bond - 1.12% -0.50%

Source (2)

International equities were relatively flat as the MSCI EAFE Index (Europe, Australasia, Far East) was up 0.70% for the month and is now up just over 8% on the year. However, the Delta Variant is causing real problems in those countries with less access to the vaccine as the MSCI Emerging Markets index fell over 7% during the month of July and it is now down over 1% on the year.2

THE DELTA VARIANT

The vaccine rollout continued its progress through July as more states began to ease economic restrictions. However, this progress has hit a bump in the road as the more contagious Delta variant of the virus begins to spread. The economic reopening of the country is still well on its way, but it might take longer than expected as some local governments are beginning to tighten restrictions, specifically regarding mask mandates. As of July 31st, the seven-day moving average is 72,000 COVID-19 cases per day, 6,200 hospital admissions per day, and 300 deaths per day, according to data from the Centers for Disease Control and Prevention (CDC). These numbers have each increased by over 25% week-over-week. Initial research found that breakthrough infections (vaccinated individuals getting the virus) occurred at rates of 2% or less, however, the CDC published data on Friday, July 31st, that found 74% of 469 infections in an outbreak in the Cape Cod and Provincetown region were in people who were vaccinated.3

Source (4)

Source (5)

On a positive note, the overall national vaccination rate is increasing. More than 3 million Americans have received a first shot of a COVID-19 vaccine in the past seven days. As of August 2nd, at least 49.7% of people in the U.S. have now been fully vaccinated, and 70.0% of those over 18 years of age have received one shot, according to the CDC.3 There is still more research to be done, and regardless of your opinion, this is something that health officials and governments will be taking seriously for the foreseeable future. We do not believe that this will hinder economic growth the way that the initial variant did in early 2020, but it is something to monitor as we move forward, particularly regarding how state and local governments react.

CONGRESS

Continuing with discussions of government reactions, not much progress was made during the month of July regarding President Biden’s infrastructure bill. After months of discussion, the Senate introduced their version of the bipartisan infrastructure bill on Sunday, August 1st, with hopes of passing it by August 9th prior to the monthlong Senate recess. Senate Majority Leader Chuck Schumer hopes to pass this $1 trillion infrastructure bill along with a separate budget measure that would allow Democrats to approve a separate $3.5 trillion spending package without a Republican vote. The House of Representative is not scheduled back in Washington until September 20th, so it will likely be a while before either bill reaches the desk of President Biden. While midterm elections occurring in November of this year could cause even more of a delay, House Speaker Nancy Pelosi has said that she has no interest in bringing up either bill in the House until both pass through the Senate. This has caused quite the stir among Republicans as most would prefer the passing of the $1 trillion bipartisan infrastructure bill and not the budget measure.6 Not including the two bills mentioned, since March of 2020, the amount of government aid is nearly $6 trillion.7

ECONOMIC DATA

According to a Reuters survey, the economy likely grew at an annualized rate of 8.5% in the second quarter of 2021 which would be the second-fastest GDP growth pace since the second quarter of 1983. First quarter GDP growth checked in at a rate of 6.4% but it is subject to revision. Similar economists project an overall growth rate of 7% for U.S. GDP in 2021, the strongest growth rate since 1984.7 Yes, there are caveats such as the large economic decline in 2020, but this is still very positive momentum for the economic outlook moving forward.



Second quarter earnings were positive as over half of the S&P 500 companies have reported with 90% of those companies beating analyst expectations.8 The national unemployment rate was 5.9% for the month of June, up slightly from the 5.8% seen in May.9 The United States added 850,000 jobs in June, which is the biggest gain since August of 2020 when the initial shutdown was ending. As more jobs are added, companies are finding it more difficult to higher skilled workers which is leading to higher wage growth as potential employees are demanding higher wages. The consumer price index (CPI) was up 5.4% year over year in June as the number surprised for a fourth consecutive month.8

Source (10)

INFLATION AND THE FED

Inflation was still in the headlines throughout July, and while many people look to the CPI as a proxy for inflation, the Federal Reserve Board (the Fed) focuses on the personal consumption expenditure deflator, or PCE-deflator, as it discusses policy. The PCE-deflator was up 4.0% in June of 2021 relative to June of 2020, and it is 0.5% higher than it was in May of this year. Excluding food and energy prices which tend to move more erratically, prices were still up 3.5% from a year ago and up 0.4% month over month. While the Fed has taken a more hawkish stance as of late, the higher than anticipated rise in inflation has challenged the Fed’s timeframe for tightening monetary policy, and on July 28th, the Fed announced its intention to leave interest rates and bond purchases unchanged for now.  The Fed is set to revisit tapering bond purchase during the August meeting and most believe they will begin to implement before the end of the calendar year.11

CONCLUSION

The S&P 500 increased for the fifth straight month in July; its longest winning streak since 2018, but treasury yields in the U.S. are the lowest they’ve been in 18 months. According to Hugh Gimber, Global Market Strategist of J.P. Morgan, such a sharp decline in yields would normally imply a significant downgrade to the growth outlook, but there appears to be a wide range of factors behind the move. Demand has been strong as you combine the Fed’s purchases with institutional investors looking to rebalance at the end of the quarter as they take some of their equity gains off of the table. Hugh believes that the bond market is not sending a negative signal about the health of the economy. The current level of Treasury yields appears inconsistent with the strength of the recovery, and in our base case we expect yields to move higher over the remainder of the year.8 To quote Fed policy makers, “The path of the economy continues to depend on the course of the virus.” 1 Growth potential still remains as consumers have plenty of money to spend while the Fed and government officials continue to provide their support. However, the wildcard in this scenario is the Delta variant of the Covid-19 virus. If you asked us in early March of 2020, almost none of us could have envisioned the future large-scale shutdown and the effect on our economy that would follow, and I’m sure most of us are thinking the same thing as of now. While we have a much better handle on health and safety protocols, this is still a new variant of the virus with a small sample size of research relative to the initial alpha variant. As we move through the month of August, Greg Bassuk, CEO of AXS Investments, states, “Of all the months to date, August is really going to be that watershed month where we have enough information between Covid, earnings and economic data that will give investors greater confidence in where we’re moving and the balance of the year.” 1 So, while there is growth potential, it is likely going to be a volatile remainder of the year and we will need continuing monitoring both the virus and the Fed/government response. If you’d like to revisit your portfolio and/or discuss your risk tolerance, please reach out to schedule a meeting today. 

1 – https://www.forbes.com/advisor/investing/august-2021-stock-market-outlook/

2 – https://www.investing.com/indices/major-indices

3 – https://www.marketwatch.com/story/the-delta-variant-is-more-than-twice-as-contagious-as-previous-strains-of-the-virus-federal-health-officials-say-as-they-urge-vaccinations-11627942638

4 – https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases

5 – https://covid.cdc.gov/covid-data-tracker/#vaccinations

6 – https://www.cnbc.com/2021/08/02/infrastructure-senate-to-vote-on-bipartisan-bill.html

7 – https://www.reuters.com/world/us/fiscal-stimulus-vaccines-likely-fueled-us-economic-growth-second-quarter-2021-07-29/

8 – https://am.jpmorgan.com/content/dam/jpm-am-aem/global/en/insights/market-insights/mi-monthly-market-review.pdf

9 – https://www.statista.com/statistics/273909/seasonally-adjusted-monthly-unemployment-rate-in-the-us/

10 – https://www.bls.gov/cpi/

11 – https://www2.deloitte.com/us/en/insights/economy/global-economic-outlook/weekly-update.html-2021-06-16/

Returns are based on the S&P 500 Total Return Index, an unmanaged, capitalization-weighted index that measures the performance of 500 large capitalization domestic stocks representing all major industries. Indices do not include fees or operating expenses and are not available for actual investment. The hypothetical performance calculations are shown for illustrative purposes only and are not meant to be representative of actual results while investing over the time periods shown. The hypothetical performance calculations for the respective strategies are shown gross of fees. If fees were included returns would be lower. Hypothetical performance returns reflect the reinvestment of all dividends. The hypothetical performance results have certain inherent limitations. Unlike an actual performance record, they do not reflect actual trading, liquidity constraints, fees and other costs. Also, since the trades have not actually been executed, the results may have under- or overcompensated for the impact of certain market factors such as lack of liquidity. Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. Returns will fluctuate and an investment upon redemption may be worth more or less than its original value. Past performance is not indicative of future returns. An individual cannot invest directly in an index.


This material has been prepared for information and educational purposes and should not be construed as a solicitation for the purchase or sell of any investment. The content is developed from sources believed to be reliable. This information is not intended to be investment, legal or tax advice. Investing involves risk, including the loss of principal. No investment strategy can guarantee a profit or protect against loss in a period of declining values. Investment advisory services offered by duly registered individuals on behalf of ChangePath, LLC a Registered Investment Adviser.

03 Dec, 2021
November was a dizzying month for investors. The highlight? Earnings. 82% of companies1 beat estimates this quarter, despite headwinds such as supply chain constraints and inflation. The market’s biggest muse? Elon Musk’s twitter handle, with tweets such as (paraphrased) “should I sell 10% of my Tesla stock?” The most exciting job? Fed watcher. We started tapering, saw a plethora of hot inflation data, and gleaned insight from Federal Reserve Chair Jerome Powell on the last day of the month. November 2021 Market Returns 
03 Dec, 2021
October was another positive month for the markets after September’s pullback. So far in 2021, the S&P 500 had nine positive performing months, September being the only hold out. The index ended up 6.9%, even though the first week of the month started a bit volatile. However, 2021 is looking robust, even if November and December aren’t large contributors, as the YTD performance through October is 23.9%. 1 
By Rob Kellogg, CFA® 07 Oct, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 Sep, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Jun, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 07 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 May, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 08 Apr, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 09 Mar, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
By Rob Kellogg, CFA® 05 Feb, 2021
As discussed in last month’s commentary, we felt November was going to be one of the more pivotal months that this country has seen in quite some time. Well, November lived up to its billing. As the page turned to the final month of the year, November experienced one of the most divisive U.S. Presidential Elections, the announcement of multiple vaccines’ effectiveness, and new all-time highs in the equity markets. December is sure to be intense as well while President Trump continues to contest the election, and as many states are determining how to handle the rise in cases of COVID-19 in tandem with the potential distribution of a vaccine. December will close the book on what has been one of the most interesting years in many of our lifetimes. We will keep this month’s commentary brief as we look forward to recapping the year in our annual commentary next month.
More Posts
Share by: